Identification of novel potent peptide inhibitors targeting the polo-box domain of PLK1: structure-based pharmacophore modelling, virtual screening, molecular docking, molecular dynamics study and biological evaluation

Multiple myeloma, a hematological malignancy, shows PLK1 overexpression in cells correlates with poor prognosis, suggesting PLK1 as a potential therapeutic target. In this study, we discovered five peptides (PLs 1–5) targeting the polo box domain (PBD) of PLK1 through an integrated virtual screening...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hong Zhou, Lixia Guan, Guoqiang Lin, Xiaotian Yang, Xingxia Zhang, Yejun Si, Yanming Zhang, Juan Chen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2025-12-01
Colección:	Journal of Enzyme Inhibition and Medicinal Chemistry
Materias:	Multiple myeloma polo-like kinase 1 (PLK1) polo box domain (PBD) structure-based virtual screening
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/14756366.2025.2563601
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!